These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 8418770)

  • 1. Oral anticoagulant therapy in the chronic phase of myocardial infarction.
    Smith P
    Arch Pathol Lab Med; 1993 Jan; 117(1):97-101. PubMed ID: 8418770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticoagulant or antiaggregant therapy in the secondary prevention of myocardial infarct?].
    De Caterina R; Gianetti J; Simonetti I; Gensini G
    G Ital Cardiol; 1996 Nov; 26(11):1309-21. PubMed ID: 9036028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prescription of heparin in the acute phase of myocardial infarction: expected and observed benefits...].
    Cador R; Weber S
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1479-84. PubMed ID: 9092406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation system pathophysiology in acute myocardial infarction: the influence of anticoagulant treatment on laboratory findings.
    Fletcher AP; Alkjaersig NK; Ghani FM; Tulevski V; Owens O
    J Lab Clin Med; 1979 Jun; 93(6):1054-65. PubMed ID: 438607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
    Reikvam A; Madsen S; Landmark K
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
    Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
    Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction.
    Wray R; Maurer B; Shillingford J
    N Engl J Med; 1973 Apr; 288(16):815-7. PubMed ID: 4571525
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey].
    Spitzer W; Durst OE; Lang E
    Fortschr Med; 1983 Jan; 101(1-2):22-30. PubMed ID: 6826125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of anticoagulant oral treatment in patients with thrombus in left ventricle after acute myocardial infarction].
    Carrillo AM; Valdespino A; Solorio S; Badui E; Enciso R; Lepe L; Lara A; Ocampo S; Alonso R; Romero MA
    Arch Inst Cardiol Mex; 1997; 67(3):217-22. PubMed ID: 9412434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ximelagatran: a new oral anticoagulant.
    Hrebickova L; Nawarskas JJ; Anderson JR
    Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hospital course of acute myocardial infarction treated with or without anticoagulants].
    Hurtado L; Adabache M; López Escárcega F; Cárdenas M
    Arch Inst Cardiol Mex; 1984; 54(5):463-70. PubMed ID: 6517643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
    Gianetti J; Gensini G; De Caterina R
    Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current role of anticoagulants in cardiovascular medicine.
    De Caterina R
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):595-604. PubMed ID: 19571765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.
    Andreotti F; Testa L; Biondi-Zoccai GG; Crea F
    Eur Heart J; 2006 Mar; 27(5):519-26. PubMed ID: 16143706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.